ASPIRA PATHLAB & DIAGNOSTICS
Back to Cashflow Statement
|
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Cash Flow from Operating Activities | ₹1.83 Cr | ₹1.05 Cr |
What is the latest Cash Flow from Operating Activities ratio of ASPIRA PATHLAB & DIAGNOSTICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.83 Cr |
| Mar2024 | ₹1.05 Cr |
How is Cash Flow from Operating Activities of ASPIRA PATHLAB & DIAGNOSTICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.83 Cr | 73.34 | |
| Mar2024 | ₹1.05 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ASPIRA PATHLAB & DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASPIRA PATHLAB & DIAGNOSTICS | ₹122.7 Cr | -16.9% | 28.1% | 102% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹113,734.0 Cr | -9.1% | -10% | 7.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹87,987.2 Cr | -8.1% | -9.1% | -17.6% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹59,635.5 Cr | -7% | -13.1% | 10.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹57,603.3 Cr | -6.8% | -16.4% | -21.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,288.0 Cr | -4.2% | -8.2% | -2.9% | Stock Analytics | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | -16.9% |
28.1% |
102% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses